Status: Available
Glioblastoma and Individualized Therapies
The treatment of patients with World Health Organization (WHO) grade 4 malignant glioma has not seen any significant breakthrough the past years. Following surgery and radio / chemotherapy patients still experience a very high recurrence risk and the prognosis is dismal. The investigators observed patients with grade IV malignant glioma receiving individualized treatment based on their molecular profile including fully personalized vaccines.
Trial details
Biological sex: AllType: Expanded AccessSponsor: Zentrum fur Humangenetik TuebingenUpdated: Mar 1, 2024Locations: 1
Eligibility criteria
malignant glioma, IDH WT
na